TechNavio’s analysts forecast the Global Atherectomy Devices market to grow at a CAGR of 11.48 percent and the Global Thrombectomy Devices market to grow at a CAGR of 8.14 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of Abdominal Aortic Aneurysm and Peripheral Arterial Disease worldwide. The Global Atherectomy and Thrombectomy Devices market has also been witnessing an increase in patent grants and US FDA approvals. However, the adverse effects of atherectomy and thrombectomy devices could pose a challenge to the growth of this market.
TechNavio’s report, Global Atherectomy and Thrombectomy Devices Market 2012-2016, has been prepared based on an in-depth market analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it covers the Global Atherectomy and Thrombectomy Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating the Global Atherectomy Devices market are Bayer AG, Boston Scientific Corp., Cardiovascular Systems Inc., Covidien plc, and Spectranetics Corp.
The key vendors dominating the Global Thrombectomy Devices market are Bayer AG, Boston Scientific Corp., Covidien plc, Getinge AB, Spectranetics Corp., Straub Medical AG, and Vascular Solutions Inc.
The other vendors mentioned in the report are 3M Co., American Heart Association Inc., Aerotel Medical Systems Ltd., Asian Heart Institute, Cook Medical Inc., ev3 Inc., Heartware International Ltd., Nihon Kohden Corp., Smith & Nephew plc, Sorin Group USA Inc., St. Jude Medical Inc., Terumo Medical Corp., Ventracor Ltd., Uscom Ltd., and Zoll Medical Corp.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of each of these key vendors?
1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Research Methodology
5. Scope of the Report
Market Overview
Product Offerings
6. Market Landscape
6.1. Global Peripheral Vascular Devices Market
Market Size and Forecast
6.2. Key Market Segmentation
6.3. Global Atherectomy Devices Market
Market Size
Market Forecast
6.4. Key Market Segmentation of Atherectomy Devices
6.5. Atherectomy Devices Market in the US
Market Size and Forecast
6.6. Global Thrombectomy Devices Market
Market Size
Market Forecast
6.7. Key Market Segmentation of Thrombectomy Devices
6.8. Thrombectomy Devices Market in the US
Market Size and Forecast
6.9. Five Force Analysis
7. Geographical Segmentation
8. Key Leading Countries
USA
Japan
Germany
9. Rate of Incidence and Prevalence
Diabetes
Cancer
AIDS
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
17.1. Bayer AG
17.1.1. Business Overview
17.1.2. Business Segmentation
17.1.3. Key Information
17.1.4. SWOT Analysis
17.2. Boston Scientific Corp.
17.2.1. Business Overview
17.2.2. Business Segmentation
17.2.3. Key Information
17.2.4. SWOT Analysis
17.3. Covidien plc
17.3.1. Business Overview
17.3.2. Business Segmentation
17.3.3. Key Information
17.3.4. SWOT Analysis
17.4. Getinge AB
17.4.1. Business Overview
17.4.2. Business Segmentation
17.4.3. Key Information
17.4.4. SWOT Analysis
17.5. Vascular Solutions Inc.
17.5.1. Business Overview
17.5.2. Business Segmentation
17.5.3. Key Information
17.5.4. SWOT Analysis
18. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Peripheral Vascular Devices Market 2012–2016 (US$ billion)
Exhibit 2: Global Peripheral Vascular Devices Market by Category Segmentation
Exhibit 3: Global Atherectomy Devices Market 2012–2016 (US$ million)
Exhibit 4: Category Segmentation of Atherectomy Devices
Exhibit 5: Atherectomy Devices Market in the US 2012–2016 (US$ million)
Exhibit 6: Global Thrombectomy Devices Market 2012–2016 (US$ million)
Exhibit 7: Category Segmentation of Thrombectomy Devices
Exhibit 8: Thrombectomy Devices Market in the US 2012–2016 (US$ million)
Exhibit 9: Global Atherectomy Devices Market by Geographical Segmentation 2012
Exhibit 10: Global Thrombectomy Devices Market by Geographical Segmentation 2012
Exhibit 11: Global Atherectomy Devices Market by Vendor Segmentation 2012
Exhibit 12: Global Thrombectomy Devices Market by Vendor Segmentation 2012
Exhibit 13: Business Segmentation of Bayer AG
Exhibit 13: Business Segmentation of Boston Scientific Corp.
Exhibit 13: Business Segmentation of Covidien plc
Exhibit 13: Business Segmentation of Getinge AB
Exhibit 13: Business Segmentation of Vascular Solutions Inc.
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600